Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
NeuroBo Pharmaceuticals, Inc. (GEMP)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
4
| Kim Hyung Heon (CEO & President) has filed a Form 4 on NeuroBo Pharmaceuticals, Inc.|
Txns:
| Granted 625,064 shares
@ $0 |
|
| 07/28/2023 |
4
| KOVEN ANDREW I (Director) has filed a Form 4 on NeuroBo Pharmaceuticals, Inc.|
Txns:
| Granted 87,500 shares
@ $0
Granted 12,500 shares
@ $0 |
|
| 07/28/2023 |
4
| Salsbury Michael (Director) has filed a Form 4 on NeuroBo Pharmaceuticals, Inc.|
Txns:
| Granted 87,500 shares
@ $0
Granted 12,500 shares
@ $0 |
|
| 07/28/2023 |
4
| STRICKLAND D GORDON (Director) has filed a Form 4 on NeuroBo Pharmaceuticals, Inc.|
Txns:
| Granted 87,500 shares
@ $0
Granted 12,500 shares
@ $0 |
|
| 07/28/2023 |
4
| GROVES JASON L (Director) has filed a Form 4 on NeuroBo Pharmaceuticals, Inc.|
Txns:
| Granted 87,500 shares
@ $0
Granted 12,500 shares
@ $0 |
|
| 07/28/2023 |
4
| Glickman Mark A (Director) has filed a Form 4 on NeuroBo Pharmaceuticals, Inc.|
Txns:
| Granted 25,000 shares
@ $0
Granted 12,500 shares
@ $0 |
|
| 07/28/2023 |
4
| Kim Na Yeon (10% Owner) has filed a Form 4 on NeuroBo Pharmaceuticals, Inc.|
Txns:
| Granted 87,500 shares
@ $0
Granted 12,500 shares
@ $0 |
|
| 07/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/28/2022 |
4
| Kim Na Yeon (10% Owner) has filed a Form 4 on NeuroBo Pharmaceuticals, Inc.|
Txns:
| Disposed of 1,445,267 shares
@ $0 |
|
| 06/13/2022 |
4
| Kim Na Yeon (10% Owner) has filed a Form 4 on NeuroBo Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.4725, valued at
$9.5k
|
|
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2022 |
4
| Kim Hyung Heon (Director) has filed a Form 4 on NeuroBo Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.4725, valued at
$9.5k
|
|
| 06/10/2022 |
4
| Kang Richard (Director) has filed a Form 4 on NeuroBo Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.4725, valued at
$9.5k
|
|
| 06/10/2022 |
4
| STRICKLAND D GORDON (Director) has filed a Form 4 on NeuroBo Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.4725, valued at
$9.5k
|
|
| 06/10/2022 |
4
| Salsbury Michael (Director) has filed a Form 4 on NeuroBo Pharmaceuticals, Inc.|
Txns:
| Granted 20,000 options to buy
@ $0.4725, valued at
$9.5k
|
|
| 06/10/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/02/2022 |
4
| STRICKLAND D GORDON (Director) has filed a Form 4 on NeuroBo Pharmaceuticals, Inc.|
Txns:
| Granted 40,000 options to buy
@ $1.02, valued at
$40.8k
|
|
| 11/04/2021 |
4
| Price Ben Gil (CEO and President) has filed a Form 4 on NeuroBo Pharmaceuticals, Inc.|
Txns:
| Granted 616,666 options to buy
@ $2.04, valued at
$1.3M
|
|
| 09/03/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/05/2021 |
4
| Bakshi Akash (SVP and COO) has filed a Form 4 on NeuroBo Pharmaceuticals, Inc.|
Txns:
| Granted 29,013 shares
@ $0
Granted 855,059 shares
@ $0 |
|
| 09/03/2020 |
4
| Swirsky Douglas J (Director) has filed a Form 4 on NeuroBo Pharmaceuticals, Inc.|
Txns:
| Granted 60,000 options to buy
@ $6.04, valued at
$362.4k
|
|
| 01/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/15/2020 |
4
| Jeong Tae Heum (Director) has filed a Form 4 on NeuroBo Pharmaceuticals, Inc.|
Txns:
| Granted 60,000 options to buy
@ $8.39, valued at
$503.4k
|
|
| 01/15/2020 |
4
| Gullans Steven R. Ph.D. (Director) has filed a Form 4 on NeuroBo Pharmaceuticals, Inc.|
Txns:
| Granted 60,000 options to buy
@ $8.39, valued at
$503.4k
|
|
| 01/15/2020 |
4
| GROVES JASON L (Director) has filed a Form 4 on NeuroBo Pharmaceuticals, Inc.|
Txns:
| Granted 60,000 options to buy
@ $8.39, valued at
$503.4k
|
|
| 01/02/2020 |
4
| Versavel Mark (Chief Medical Officer) has filed a Form 4 on NeuroBo Pharmaceuticals, Inc.|
Txns:
| Granted 297,206 options to buy
@ $0.63, valued at
$187.2k
Granted 45,724 options to buy
@ $0.63, valued at
$28.8k
|
|
| 01/02/2020 |
4
| Oh Jeong Gyun (10% Owner) has filed a Form 4 on NeuroBo Pharmaceuticals, Inc.|
Txns:
| Granted 1,817,842 shares
@ $0
Granted 240,051 shares
@ $0 |
|
| 01/02/2020 |
4
| Kim Na Yeon (10% Owner) has filed a Form 4 on NeuroBo Pharmaceuticals, Inc.|
Txns:
| Granted 4,335,800 shares
@ $0
Granted 1,121,190 shares
@ $0
Granted 1,864,799 shares
@ $0 |
|
| 07/26/2019 |
4
| SASSINE ANDY (Director) has filed a Form 4 on Gemphire Therapeutics Inc.|
Txns:
| Granted 15,000 shares
@ $0 |
|
| 07/26/2019 |
4
| LICHTINGER PEDRO (Director) has filed a Form 4 on Gemphire Therapeutics Inc.|
Txns:
| Granted 15,000 shares
@ $0 |
|
| 07/26/2019 |
4
| KOUSKY KENNETH W (Director) has filed a Form 4 on Gemphire Therapeutics Inc.|
Txns:
| Granted 15,000 shares
@ $0 |
|
| 07/26/2019 |
4
| Reno Seth (Chief Commercial Officer) has filed a Form 4 on Gemphire Therapeutics Inc.|
Txns:
| Granted 100,000 shares
@ $0 |
|
|
|
|